Archives
-
Toremifene Versus Tamoxifen in Advanced Breast Cancer
2026-09-03
This Cochrane review evaluated whether toremifene offers clinically meaningful advantages over tamoxifen for advanced breast cancer. Its comparative synthesis found broadly similar efficacy and tolerability, while highlighting the importance of interpreting selective estrogen receptor modulator studies within their clinical context rather than assuming mechanistic differences automatically produce superior patient outcomes.
-
In Vitro Drug Response Metrics in Cancer
2026-09-03
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent drug-response dimensions. The framework supports more interpretable cancer biology experiments by combining endpoint-specific measurements with attention to response timing.
-
Angiotensin II: Practical Research Protocols
2026-09-02
Angiotensin II (SKU A1042) provides a defined peptide stimulus for receptor-signaling assays, vascular smooth muscle cell hypertrophy research, hypertension mechanism study, and vascular remodeling models. It is intended for controlled scientific experiments only, not for diagnostic, therapeutic, or medical use.
-
Hydroxytyrosol in Oxidative Stress Research
2026-09-02
Hydroxytyrosol, also called 4-(2-hydroxyethyl)benzene-1,2-diol, is a high-purity olive-derived phenolic compound for in vitro antioxidant and inflammation research. Its chemical reactivity supports oxidative stress assays, but the nicotine–chronic kidney disease literature does not establish Hydroxytyrosol as a treatment for kidney disease.
-
Lisinopril Dihydrate: Assay Interpretation Guide
2026-09-01
Lisinopril dihydrate is more than a standard ACE inhibitor: it is a mechanistic probe for separating ACE-dependent biology from aminopeptidase effects. This guide connects molecular selectivity, assay controls, and cardiovascular and renal disease models to improve interpretation of experimental results.
-
DOPE: From Membrane Fusion to Lipid Redox Biology
2026-09-01
1,2-Dioleoyl-sn-glycero-3-PE (DOPE) is more than a helper lipid: it is a formulation variable that can influence endosomal escape, transfection performance, and how researchers interpret lipid biology. This thought-leadership article connects DOPE’s established role in nucleic acid delivery with findings from Magnaporthe oryzae research showing that phospholipid metabolism and lipid peroxidation shape fungal pathogenicity. It also defines the limits of that cross-domain analogy and offers a practical framework for selecting, preparing, and validating DOPE in translational workflows.
-
BFH772 (VEGFR2 inhibitor): Protocol Guide
2026-08-31
BFH772 (VEGFR2 inhibitor) provides a selective small-molecule tool for testing VEGFR2-dependent angiogenesis rather than broad kinase inhibition. This guide covers solvent-compatible preparation, controls, and QC; it is not appropriate for water-based formulations, and dossier-reported in vivo or clinical context should not be treated as a validated protocol outcome.
-
IDH2-Driven Metabolic Reprogramming in CRC
2026-08-31
The reference study identifies elevated IDH2 as a metabolic driver of colorectal cancer progression, linking reductive citrate-cycle activity to α-ketoglutarate handling, mitochondrial ATP production, glycolysis, and HIF-1A signaling. Its combined genetic, pharmacological, metabolic, and in vivo evidence provides a framework for testing how altered α-ketoglutarate availability affects hypoxia biology in CRC models.
-
Ferrostatin-1: Practical Ferroptosis Workflows
2026-08-30
Ferrostatin-1 (Fer-1) turns ferroptosis rescue into a practical experimental variable for cell, tissue-engineering, cancer biology, and neurodegenerative disease models. This guide translates the latest tracheal regeneration study into dosing, assay-design, troubleshooting, and interpretation strategies.
-
Rimonabant (SR141716) in CB1 Research
2026-08-29
Rimonabant (SR141716) gives researchers a selective way to test whether appetite, inflammatory, or pain-related phenotypes depend on CB1 signaling. This practical guide combines formulation, receptor, cellular, behavioral, and cross-pathway workflows with troubleshooting strategies for cleaner interpretation.
-
CD28–ARS2–PKM Splicing in CD8+ T Cells
2026-08-28
Holling and colleagues identify a CD28–ARS2 signaling axis that reshapes PKM alternative splicing and gives activated CD8+ T cells greater flexibility in glucose metabolism. The study connects post-transcriptional RNA regulation with interferon-γ production and antitumor function, while showing that this metabolic branch is distinct from canonical CD28–PI3K signaling.
-
SETD7 Depletion Promotes White Adipose Browning
2026-08-28
The reference study identifies SETD7 as a negative regulator of thermogenesis in inguinal white adipose tissue rather than a general controller of adipocyte formation. Genetic SETD7 depletion enhanced beige-fat activity through an Adcy7–Sirt1–Creb1 pathway and improved energy expenditure and metabolic health in obese mice.
-
Prednisone Assays: From Mechanism to Measurement
2026-08-27
Prednisone is a synthetic corticosteroid whose effects on G1 arrest, IL-2 signaling, and lymphocyte apoptosis can be studied through a transformation-aware assay strategy. This guide connects immunology workflow design with LC–MS/MS lessons from recent botanical research without confusing digestive stability with corticosteroid pharmacology.
-
Angiotensin II: Applied Research Workflow Guide
2026-08-27
Build reproducible cell and animal studies with Angiotensin II, from GPCR-proximal signaling and vascular smooth muscle cell hypertrophy to pressure, vascular reactivity, remodeling, and renal injury endpoints. A reference-grounded workflow also shows how metabolomics-informed interventions can be evaluated without confusing disease-model improvement with direct peptide performance.
-
Psora 4: Practical Kv1.3 Blocker Workflows
2026-08-26
Psora 4 gives immune researchers a selective way to probe Kv1.3-dependent membrane potential, Ca2+ entry, and effector-memory T-cell activity. This workflow-focused guide covers stock preparation, kinetic assay design, cell-state controls, anti-GBM model interpretation, and troubleshooting.